Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02227303 · ClinicalTrials.gov registry record · NA

A Pilot Open Label Clinical Trial to Evaluate the Combined Impact of Two Mobile Health Products on Health Outcomes in Overweight Adults With Type 2 Diabetes

A NA study of Type 2 Diabetes Mellitus, sponsored by Medidata Solutions.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT02227303 is a NA study of Type 2 Diabetes Mellitus that has completed, run by Medidata Solutions. The registered enrollment target is 23 participants, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02227303, a NA study of Type 2 Diabetes Mellitus, has completed, sponsored by Medidata Solutions.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to explore the effect of 8-weeks use of the Medidata Patient Cloud (a mobile application for capturing data directly from subjects, enabling entry of diary and quality of life data into internet-enabled devices) in combination with an activity tracker (Fitbit Flex) on health outcomes in overweight people with Type 2 Diabetes.

Conditions Studied

Interventions

  • BEHAVIORAL lifestyle modification instructional and motivational sessions

Study Locations (1)

Florida

  • Miami Research Associates (MRA) - Miami

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2014-08
Est. Completion 2015-03
Phase NA

Sponsor

Medidata Solutions

1 total trials

What the Registry Record Tells You About NCT02227303

The ClinicalTrials.gov registry entry for NCT02227303 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The listed sponsor is Medidata Solutions, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which lifestyle modification instructional and motivational sessions is the first listed.

NCT02227303 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02227303 about?

NCT02227303 is a clinical study titled "A Pilot Open Label Clinical Trial to Evaluate the Combined Impact of Two Mobile Health Products on Health Outcomes in Overweight Adults With Type 2 Diabetes". The purpose of this study is to explore the effect of 8-weeks use of the Medidata Patient Cloud (a mobile application for capturing data directly from subjects, enabling entry of diary and quality of life data into internet-enabled devices) in combination with an activity tracker (Fitbit Flex) on he...

What is the current status of trial NCT02227303?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2014-08. Estimated completion is 2015-03.

What conditions does trial NCT02227303 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT02227303?

The interventions under investigation include: lifestyle modification instructional and motivational sessions (BEHAVIORAL).

Who is sponsoring clinical trial NCT02227303?

This trial is sponsored by Medidata Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02227303 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.